Catumaxomab Completed Phase 3 Trials for Carcinoma / Neoplasm / Ascites, Malignant / Cancer Treatment

Indications	Status	Purpose	Phase
DBCOND0022280 (Carcinoma) DBCOND0017273 (Neoplasm) DBCOND0110262 (Ascites, Malignant) DBCOND0020966 (Cancer)	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT00822809	CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers	Catumaxomab (DB06607) Prednisolone (DB00860)